v3.26.3
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Thousands
 9 Months Ended
Sep. 30, 2026
Sep. 30, 2025
Cash flows from operating activities    
Net loss $ 12,177 $ (43,187)
Adjustments to reconcile net income (loss) to cash provided by (used in) operating activities:    
Stock-based compensation 7,604 2,343
Depreciation and amortization 1,249 897
(Gain) loss from change in fair value of warrant liability (59,335) 14,298
Amortization of debt discount and issue costs 7,155 1,385
Paid-in-kind non-cash interest 3,267 1,567
Provision for obsolete and slow-moving inventory 1,467 0
Loss from unconsolidated subsidiary 0 (1,344)
Gain from disposal of investment in unconsolidated subsidiary 0 (3,204)
Gain on sale of Atlas (26) (140)
Loss on extinguishment of debt 0 173
Warranties issued and remediation added 2,235 2,073
Warranty recoverable from manufacturer 60 271
Credit loss provisions (credits) 16 566
Deferred income taxes 229 425
Lease expense 784 884
Impact on cash from changes in operating assets and liabilities:    
Accounts receivable (2,003) (9,875)
Inventories 21 2,489
Prepaid and other current assets (9,850) (399)
Other assets (191) (344)
Accounts payable 2,823 3,150
Accruals and other current liabilities 33,763 5,696
Deferred revenue 1,500 (898)
Other non-current liabilities (1,021) (1,208)
Lease payments and other, net (847) (1,034)
Net cash provided by (used in) operations 1,077 (25,416)
Cash flows from investing activities:    
Purchases of property and equipment (885) (793)
Proceeds from sale of Atlas software platform 26 140
Proceeds from sale of property and equipment 0 6
Proceeds from disposal of investment in unconsolidated subsidiary 0 3,204
Net cash (used in) provided by investing activities (859) 2,557
Cash flows from financing activities:    
Repayments of borrowings (7,406) 0
Proceeds from borrowings 0 35,955
Proceeds from sale of common stock 3,335 0
Stock offering costs paid (78) 0
Financing costs paid (465) (58)
Finance lease principal payments (24) 0
Proceeds from stock option exercises 0 3
Net cash (used in) provided by financing activities (4,638) 35,900
Effect of exchange rate changes on cash, cash equivalents and restricted cash (1) 81
Increase (decrease) in cash, cash equivalents and restricted cash (4,421) 13,122
Cash and cash equivalents at beginning of period 21,105 11,247
Cash and cash equivalents at end of period 16,684 24,369
Supplemental disclosures of cash flow information:    
Purchases of property and equipment included in ending accounts payable and accruals 100 167
Fair value of common stock issued upon warrant exercise 2,023 7,927
Right-of-use asset and lease liability recognition for new leases 1,380 526
Paid-in-kind and exit fee non-cash interest added to debt 3,267 1,567
Cash paid during the period for interest 2,268 263
Cash paid during the period for taxes, net of refunds $ 189 $ 12